Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics Inc. (Nasdaq: STIM) said Executive Vice President, Chief Financial Officer and Treasurer Steven E. Pfanstiel will leave the company, with his departure effective May 1, 2026, …
Neuronetics CFO Steven Pfanstiel to Depart in May Read More MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) reported higher fourth-quarter and full-year 2025 revenue, narrowed its losses, posted positive operating cash flow in the fourth quarter, and said Dan Reuvers …
Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook Read More MALVERN, PA — Neuronetics Inc. (Nasdaq: STIM) said it has appointed Dan Reuvers as president and chief executive officer, effective Monday, succeeding Keith Sullivan, who will step down the same …
Neuronetics Appoints Dan Reuvers as CEO, Succeeding Keith Sullivan Read More MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) said it will release financial and operating results for the fourth quarter of 2025 before markets open Tuesday, March 17.
Neuronetics to Report Fourth Quarter 2025 Results March 17 Read More MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) reported selected preliminary unaudited financial results for the fourth quarter and full year 2025, citing revenue growth and positive operating cash flow in …
Malvern-Based Neuronetics Reports Preliminary 2025 Revenue Growth and Positive Cash Flow Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) will share updates on its growing portfolio of noninvasive mental health treatments during a fireside chat at the Piper Sandler 37th Annual Healthcare …
Neuronetics to Spotlight Expanding Mental Health Therapies at Major Industry Forum Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced a significant coverage expansion for its NeuroStar transcranial magnetic stimulation (TMS) therapy, as TriWest — the regional administrator for TRICARE — updated …
TRICARE Expands TMS Coverage for Teens as Neuronetics Gains Major Policy Win Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) reported significant third-quarter gains, driven by the successful integration of Greenbrook TMS and expanding adoption of its NeuroStar Advanced Therapy System. The company …
Neuronetics Sees Strong Growth and Leadership Shift as Integration Gains Momentum Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) recently announced the granting of restricted stock units (RSUs) to twelve new employees as inducement awards under its 2020 Inducement Incentive Plan.
Neuronetics Awards Equity Grants to 12 New Employees as Hiring Momentum Builds Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has entered an exclusive three-year agreement with Elite DNA Behavioral Health to become the sole provider of transcranial magnetic stimulation (TMS) devices across …
Neuronetics Expands TMS Reach Through Exclusive Partnership With Elite DNA Read More